BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9016727)

  • 1. Cancer prevention and screening in women.
    Melnikow J; Nuovo J
    Prim Care; 1997 Mar; 24(1):15-26. PubMed ID: 9016727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for gynecologic cancer. Vulvar, vaginal, endometrial, and ovarian neoplasms.
    Hall KL; Dewar MA; Perchalski J
    Prim Care; 1992 Sep; 19(3):607-20. PubMed ID: 1410066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer screening for the primary care physician.
    Ashkar K; Bulbul M; Sharara A; Hourani M; Hamadeh GN
    J Med Liban; 2001; 49(5):298-302. PubMed ID: 12243426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer screening for women older than 40 years of age.
    Runowicz CD; Goldberg GL; Smith HO
    Obstet Gynecol Clin North Am; 1993 Jun; 20(2):391-408. PubMed ID: 8367140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.
    Yaren A; Ozkilinc G; Guler A; Oztop I
    Eur J Cancer Care (Engl); 2008 May; 17(3):278-84. PubMed ID: 18419631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and early detection of oral, breast and cervical cancers: a practical approach in Indian context.
    Nair MK; Varghese C; Mathew B; Sankaranarayanan R
    J Indian Med Assoc; 1993 Apr; 91(4):94-6. PubMed ID: 8409491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
    Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
    Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.
    Lamb JD; Garcia RL; Goff BA; Paley PJ; Swisher EM
    Am J Obstet Gynecol; 2006 Jun; 194(6):1702-9. PubMed ID: 16731090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for gynecologic malignancies: A continuing responsibility.
    Runowicz CD; Fields AL
    Surg Oncol Clin N Am; 1999 Oct; 8(4):703-23, vii. PubMed ID: 10452936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for ovarian cancer prevention.
    Dann RB; Kelley JL; Zorn KK
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer.
    Kuschel B; Lux MP; Goecke TO; Beckmann MW
    Eur J Cancer Prev; 2000 Jun; 9(3):139-50. PubMed ID: 10954253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can breast and cervical cancer screening visits be used to enhance colorectal cancer screening?
    Carlos RC; Fendrick AM; Ellis J; Bernstein SJ
    J Am Coll Radiol; 2004 Oct; 1(10):769-76. PubMed ID: 17411698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone prevention strategies for breast, endometrial and ovarian cancers.
    Rice LW
    Gynecol Oncol; 2010 Aug; 118(2):202-7. PubMed ID: 20471672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers.
    Rebbeck TR
    J Clin Oncol; 2000 Nov; 18(21 Suppl):100S-3S. PubMed ID: 11060335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tumor screening with special reference to breast and prostate carcinoma].
    Jost LM
    Ther Umsch; 1997 Aug; 54(8):439-50. PubMed ID: 9381414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pill and gynecologic cancer: controversy and mystery prevail.
    Sargent MA
    J Med Assoc Ga; 1995 Sep; 84(7):320-2. PubMed ID: 7561539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer screening].
    Akaza H; Tsuruo T; Saijo N; Sone S; Isonishi S; Ohashi Y; Sobue T; Yamanaka H; Fukuda M; Maruyama M; Eguchi K; Ito K; Smith M; Milsted B
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):125-34. PubMed ID: 15675598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive pills. Prevention of ovarian cancer and other benefits.
    Berchuck A; Schildkraut J
    N C Med J; 1997; 58(6):404-7; discussion 408. PubMed ID: 9392951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.